{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T06:34:33Z","timestamp":1793342073093,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.yexcr.2025.114758","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T16:23:31Z","timestamp":1758126211000},"page":"114758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["USP11 stabilizes RALY to promote FXYD5-mediated aerobic glycolysis and aggravate pancreatic cancer progression"],"prefix":"10.1016","volume":"452","author":[{"given":"Hongmin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Langxia","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runsheng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HongBiao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114758_bib1","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2025.114758_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41575-023-00840-w","article-title":"Therapeutic developments in pancreatic cancer","volume":"21","author":"Hu","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2025.114758_bib3","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/S0140-6736(25)00261-2","article-title":"Pancreatic cancer","volume":"405","author":"Stoop","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.yexcr.2025.114758_bib4","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1053\/j.gastro.2022.03.056","article-title":"Pancreatic cancer: pathogenesis, screening, diagnosis, and treatment","volume":"163","author":"Wood","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2025.114758_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2022.2129884","article-title":"Pancreatic cancer: a review of current treatment and novel therapies","volume":"36","author":"Kolbeinsson","year":"2023","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.yexcr.2025.114758_bib6","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.semcancer.2022.09.007","article-title":"Tumor glycolysis, an essential sweet tooth of tumor cells","volume":"86","author":"Paul","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.yexcr.2025.114758_bib7","first-page":"861","article-title":"Glycolysis in the progression of pancreatic cancer","volume":"12","author":"Chang","year":"2022","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114758_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13045-022-01348-7","article-title":"Hypoxia-induced exosomal circPDK1 promotes pancreatic cancer glycolysis via c-myc activation by modulating miR-628-3p\/BPTF axis and degrading BIN1","volume":"15","author":"Lin","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.yexcr.2025.114758_bib9","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/s41419-022-05213-w","article-title":"FOXD1 facilitates pancreatic cancer cell proliferation, invasion, and metastasis by regulating GLUT1-mediated aerobic glycolysis","volume":"13","author":"Cai","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114758_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41419-023-06207-y","article-title":"FOXQ1 promotes pancreatic cancer cell proliferation, tumor stemness, invasion and metastasis through regulation of LDHA-Mediated aerobic glycolysis","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114758_bib11","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1007\/s12033-023-00923-8","article-title":"miR-1180 targets FXYD5 to regulate pancreatic cancer cells migration and invasion","volume":"66","author":"Xie","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.yexcr.2025.114758_bib12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s12672-024-01497-w","article-title":"Circ_0001068 accelerates the development of ovarian cancer by promoting FXYD5 expression through inhibiting mir-149-5p activity","volume":"15","author":"Mou","year":"2024","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.yexcr.2025.114758_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112406","article-title":"TERRA stability is regulated by RALY and polyadenylation in a telomere-specific manner","volume":"42","author":"Savoca","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.yexcr.2025.114758_bib14","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.7150\/ijbs.97397","article-title":"O-GlcNAcylated RALY contributes to hepatocellular carcinoma cells proliferation by regulating USP22 mRNA nuclear export","volume":"20","author":"Liu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2025.114758_bib15","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biocel.2017.07.008","article-title":"RNA binding protein RALY promotes protein arginine methyltransferase 1 alternatively spliced isoform v2 relative expression and metastatic potential in breast cancer cells","volume":"91","author":"Bondy-Chorney","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114758_bib16","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s12964-024-01926-x","article-title":"USP11 promotes lipogenesis and tumorigenesis by regulating SREBF1 stability in hepatocellular carcinoma","volume":"22","author":"Xu","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.yexcr.2025.114758_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41388-023-02847-8","article-title":"USP11 potentiates HGF\/AKT signaling and drives metastasis in hepatocellular carcinoma","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2025.114758_bib18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1158\/1541-7786.MCR-12-0699","article-title":"Mitoxantrone targets human ubiquitin-specific peptidase 11 (USP11) and is a potent inhibitor of pancreatic cancer cell survival","volume":"11","author":"Burkhart","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114758_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/carcin\/bgaa130","article-title":"The promoting effects of hsa_circ_0050102 in pancreatic cancer and the molecular mechanism by targeting miR-1182\/NPSR1","volume":"42","author":"Hua","year":"2021","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.yexcr.2025.114758_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41575-021-00457-x","article-title":"Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors","volume":"18","author":"Klein","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2025.114758_bib21","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","article-title":"Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention","volume":"164","author":"Stoffel","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.yexcr.2025.114758_bib22","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00018-019-03278-z","article-title":"The enhancement of glycolysis regulates pancreatic cancer metastasis","volume":"77","author":"Yang","year":"2020","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.yexcr.2025.114758_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30727","article-title":"Association analysis of FXYD5 with prognosis and immunological characteristics across pan-cancer","volume":"10","author":"Bai","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.yexcr.2025.114758_bib24","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41417-025-00878-9","article-title":"FXYD5 regulates gastric cancer cell metastasis and drug resistance by EMT modulation","volume":"32","author":"Mao","year":"2025","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yexcr.2025.114758_bib25","first-page":"301","article-title":"A FXYD5\/TGF-beta\/SMAD positive feedback loop drives epithelial-to-mesenchymal transition and promotes tumor growth and metastasis in ovarian cancer","volume":"56","author":"Bai","year":"2020","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.yexcr.2025.114758_bib26","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.biochi.2023.01.002","article-title":"Generation of the novel anti-FXYD5 monoclonal antibody and its application to the diagnosis of pancreatic and lung cancer","volume":"208","author":"Hotta","year":"2023","journal-title":"Biochimie"},{"key":"10.1016\/j.yexcr.2025.114758_bib27","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41435-022-00178-4","article-title":"RALY regulate the proliferation and expression of immune\/inflammatory response genes via alternative splicing of FOS","volume":"23","author":"Liang","year":"2022","journal-title":"Gene Immun."},{"key":"10.1016\/j.yexcr.2025.114758_bib28","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41467-021-21828-7","article-title":"RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-beta2","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.yexcr.2025.114758_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133112","article-title":"RNA binding protein RALY facilitates colorectal cancer metastasis via enhancing exosome biogenesis in m6A dependent manner","volume":"273","author":"Zhou","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.yexcr.2025.114758_bib30","article-title":"PTBP1 regulates DNMT3B alternative splicing by interacting with RALY to enhance the radioresistance of prostate cancer","volume":"11","author":"He","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.yexcr.2025.114758_bib31","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9963905","article-title":"The dual role of USP11 in cancer","volume":"2022","author":"Guo","year":"2022","journal-title":"J. Oncol."},{"key":"10.1016\/j.yexcr.2025.114758_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.107768","article-title":"USP11 deubiquitinates E-cadherin and maintains the luminal fate of mammary tumor cells to suppress breast cancer","volume":"300","author":"Qian","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114758_bib33","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2403331121","article-title":"USP11 promotes prostate cancer progression by up-regulating AR and c-Myc activity","volume":"121","author":"Pornour","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2025.114758_bib34","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.7150\/thno.102730","article-title":"DLGAP5 enhances bladder cancer chemoresistance by regulating glycolysis through MYC stabilization","volume":"15","author":"Deng","year":"2025","journal-title":"Theranostics"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003581?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725003581?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:35:36Z","timestamp":1780302936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725003581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0014482725003581"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114758","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP11 stabilizes RALY to promote FXYD5-mediated aerobic glycolysis and aggravate pancreatic cancer progression","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114758","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114758"}}